logo
Plus   Neg
Share
Email

Brenntag AG Reduces FY Operating EBITDA Outlook - Quick Facts

Brenntag AG (BNTGF.PK) released preliminary financial results for the second quarter of 2019, and adjusted its full year outlook due to current economic developments. The Group said there was a noticeable slowdown in demand in June leading to an impact on earnings.

For the second-quarter, based on preliminary figures, operating gross profit was about 723 million euros compared to 677.0 million euros, prior year. Operating EBITDA was about 266 million euros compared to 231.3 million euros, last year.

For the full year, on a comparable basis, Brenntag now expects operating EBITDA to grow by 0% to 4% (revised from a prior guidance range of 3% to 7%).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk, chief executive of electric car maker Tesla, said its own battery cells, which are under development now, will not reach high-volume production until 2022. This delay can affect the Cybertruck, Semi, and Roadster programs. He also said the company intends to increase battery cell purchases from partners Panasonic, LG & CATL, and possibly other partners. U.S. Court grants Tiffany's motion to expedite lawsuit against LVMH Moët Hennessy-Louis Vuitton. However, the court has not agreed to Tiffany request for trial before November 24. Biotech company Illumina agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. This includes $3.5 billion in cash and $4.5 billion in shares of Illumina common stock. GRAIL focuses on multi-cancer early detection from blood. It is in the process of developing the technology and providing clinical data required to launch the Galleri multi-cancer screening test.
RELATED NEWS
Follow RTT